New rapid test detects infections missed by conventional methods

A same-day diagnostic approach using metagenomic sequencing has enabled clinicians to identify previously undetected infections in critically ill children, offering a new tool for intensive care units. The technique analyses all genetic material in a patient sample to look for microbial DNA or RNA, rather than relying on growth-based culture or targeted assays.

How the test works and how it differs from routine diagnostics

Metagenomic testing reads genetic material from a clinical sample and compares it against databases of known pathogens, allowing simultaneous detection of bacteria, viruses and fungi. Because it does not require organisms to be cultured, it can pick up agents that are slow-growing, difficult to grow in the laboratory or unexpected given the clinical picture. The reported same-day turnaround is substantially faster than many conventional culture-based methods, which can take several days.

Clinical implications for paediatric intensive care

Clinicians say the approach can reveal infections that standard testing misses, potentially enabling more precise targeting of treatment for critically ill children. Faster and broader pathogen detection may reduce the time patients spend on empirical broad-spectrum antibiotics and help inform infection control decisions in high-dependency settings. However, the technique is intended to complement, not immediately replace, established laboratory methods.

Practical challenges and next steps

Adoption of metagenomic diagnostics faces hurdles including costs, the need for specialised sequencing equipment and bioinformatics expertise, and the challenge of interpreting complex results that may include non-pathogenic organisms or background contaminants. Further clinical validation, standardisation of laboratory workflows and integration into hospital diagnostics systems will be needed before the technology can be widely implemented.

Wider context

Rapid, unbiased pathogen detection is an area of growing interest in intensive care and infectious disease management. While early reports suggest metagenomic sequencing could change diagnostic practice for critically ill patients, researchers and clinicians emphasise the need for larger studies to define the test's sensitivity, specificity and clinical impact across different patient groups and settings.